Volume 16, Number 7—July 2010
Dispatch
Novel Human Parvovirus 4 Genotype 3 in Infants, Ghana
Table
Factor† | No. tested‡ | PARV4 viremia until month 24 |
||
---|---|---|---|---|
No. (%) positive | RR (95% CI) | p value§ | ||
Kitchen available | ||||
No | 137 | 15 (11.0) | 1 | |
Yes | 126 | 5 (4.0) | 0.36 (0.14–0.97) | 0.033 |
Data lacking |
16 |
|||
River close | ||||
No | 197 | 13 (6.6) | 1 | |
Yes | 69 | 10 (14.5) | 2.2 (1.01–4.78) | 0.045 |
Data lacking |
13 |
|||
Water source | ||||
Pipe | 164 | 10 (6.1) | 1 | |
Pump, well, or borehole | 88 | 10 (11.4) | 1.86 (0.81–4.31) | 0.140 |
Other | 14 | 2 (14.3) | 2.34 (0.57–9.66) | 0.241 |
Data lacking | 13 |
*PARV4, parvovirus 4; RR, relative risk; CI, confidence interval.
†Other socioeconomic factors recorded, all without association with PARV4 genotype 3 viremia, were occupation of mother, education of mother, occupation of father, education of father, number of pregnancies, age of mother, age of father, no. children in household, no. adults in household, house type, no. rooms in house, financial situation, knowledge of malaria protection, mosquito protection, electricity in household, availability of radio or television.
‡Socioeconomic interviews could not be conducted for 11 participants, and 5 questionnaires were incomplete.
§χ2 test.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.